Scaling Life Sciences

Martin Stenfeldt (M.Sc. B.A. & Econ.) is a seasoned Danish life science entrepreneur and executive with a deep understanding of the challenges and opportunities involved in scaling life science ventures. As the co-founder and former CEO of MedTrace Pharma A/S, he led the company's evolution from a startup to an international player, guiding its growth from early-stage development to Phase III clinical trials. Under his leadership, MedTrace expanded beyond its headquarters in Denmark, establishing offices in the United States and Sweden, showcasing Martin's ability to navigate the complexities of scaling across diverse markets and regulatory environments.With a comprehensive life science and entrepreneurial network across Scandinavia and the US, Martin offers a global perspective on the industry. His extensive commercial experience, gained through international roles with responsibilities and postings in the US and Germany, has equipped him with invaluable insights into the nuances of life science commercialization on a global scale. Martin's role as a Resident Industry Fellow at the Technical University of Denmark further solidifies his position as a thought leader in life sciences, enabling him to contribute to the development of innovative solutions and mentor the next generation of industry talent. In addition to his fellowship, he has held multiple board positions and actively mentors emerging startups, sharing his expertise in scaling, commercialization, and sustainable growth.